( en | de | ru )

 

Disambiguierung von "Guyatt, Gordon"

Autor der Publikation

KopierenLöschenDiese Publikation zur Ablage hinzufügen
CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration.

, , , , , , , , , , , , , , und . BMJ (Clinical research ed.), 350 (may14 15): h1793 (Mai 2015)Publicació; Checklist; RCT; N-of-1; Online.
DOI: 10.1136/bmj.h1793

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

Artur Gordon

Karina Gordon

Gordon Weinberg

Gordon Whittaker

Leo Gordon

 

Weitere Publikationen von Autoren mit dem selben Namen

The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study., , , , , , , , und . PloS one, 6 (10): e25491 (Januar 2011)6400<m:linebreak></m:linebreak>JID: 101285081; 2011/02/24 received; 2011/09/06 accepted; 2011/10/18 epublish; ppublish;.When and how to update systematic reviews: consensus and checklist, , , , , , , , , und 16 andere Autor(en). BMJ, (2016)How to ascertain drug safety in the context of benefit. Controversies and concerns., , , , , , , , , und 10 andere Autor(en). The Journal of rheumatology, 36 (9): 2114-21 (September 2009)5429<m:linebreak></m:linebreak>JID: 7501984; 0 (Antirheumatic Agents); ppublish;.Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical Literature., , , , , , , und . JAMA, 318 (14): 1377-1384 (Oktober 2017)Models predictius; Critical appraisal; Introductori.Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials, , , , , , , , , und 18 andere Autor(en). 403 (10434): e21--e31 (2024)CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement., , , , , , , , , und 3 andere Autor(en). BMJ (Clinical research ed.), 350 (may14 17): h1738 (Mai 2015)Publicació; Checklist; RCT; N-of-1; Online.Treatment effects on patient-important outcomes can be small, even with large effects on surrogate markers., , , und . Journal of clinical epidemiology, 65 (9): 940-5 (September 2012)6788<m:linebreak></m:linebreak>CI: Copyright (c) 2012; JID: 8801383; 2011/08/25 received; 2012/02/15 revised; 2012/02/19 accepted; 2012/05/18 aheadofprint; ppublish;<m:linebreak></m:linebreak>Tamaño del efecto; Surrogate endpoints.Criteria for use of composite end points for competing risks-a systematic survey of the literature with recommendations., , und . Journal of clinical epidemiology, (Februar 2017)Comparacions múltiples; Composite endpoints; Competing risks.Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest., , , und . Journal of clinical epidemiology, (Oktober 2019)Anàlisi de dades; Risc relatiu vs absolut.CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration., , , , , , , , , und 5 andere Autor(en). BMJ (Clinical research ed.), 350 (may14 15): h1793 (Mai 2015)Publicació; Checklist; RCT; N-of-1; Online.